91 related articles for article (PubMed ID: 15794940)
1. Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice.
Planavila A; Alegret M; Sánchez RM; Rodríguez-Calvo R; Laguna JC; Vázquez-Carrera M
Biochem Pharmacol; 2005 Apr; 69(8):1195-204. PubMed ID: 15794940
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
5. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
6. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
8. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
Steinberg GR; Rush JW; Dyck DJ
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II.
Cabrero A; Jové M; Planavila A; Merlos M; Laguna JC; Vázquez-Carrera M
Mol Pharmacol; 2003 Sep; 64(3):764-72. PubMed ID: 12920214
[TBL] [Abstract][Full Text] [Related]
10. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.
Kraegen EW; Saha AK; Preston E; Wilks D; Hoy AJ; Cooney GJ; Ruderman NB
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E471-9. PubMed ID: 16234268
[TBL] [Abstract][Full Text] [Related]
11. Ethanol alters lipid profiles and phosphorylation status of AMP-activated protein kinase in the neonatal mouse brain.
Saito M; Chakraborty G; Mao RF; Wang R; Cooper TB; Vadasz C; Saito M
J Neurochem; 2007 Nov; 103(3):1208-18. PubMed ID: 17683484
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
Barthel A; Krüger KD; Roth RA; Joost HG
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
[TBL] [Abstract][Full Text] [Related]
13. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
14. AMPK regulation of the growth of cultured human keratinocytes.
Saha AK; Persons K; Safer JD; Luo Z; Holick MF; Ruderman NB
Biochem Biophys Res Commun; 2006 Oct; 349(2):519-24. PubMed ID: 16949049
[TBL] [Abstract][Full Text] [Related]
15. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.
He G; Sung YM; Digiovanni J; Fischer SM
Cancer Res; 2006 Feb; 66(3):1873-8. PubMed ID: 16452250
[TBL] [Abstract][Full Text] [Related]
17. High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle.
Liu Y; Wan Q; Guan Q; Gao L; Zhao J
Biochem Biophys Res Commun; 2006 Jan; 339(2):701-7. PubMed ID: 16316631
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
19. Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMP-activated protein kinase.
Hutchinson DS; Csikasz RI; Yamamoto DL; Shabalina IG; Wikström P; Wilcke M; Bengtsson T
Cell Signal; 2007 Jul; 19(7):1610-20. PubMed ID: 17391917
[TBL] [Abstract][Full Text] [Related]
20. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin.
Palanivel R; Sweeney G
FEBS Lett; 2005 Sep; 579(22):5049-54. PubMed ID: 16137686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]